OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...
Scientists say IRX4204 given to mice with evident symptoms showed potential "as a remyelinating and neurorestorative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback